| Name: | Atorvastatin Diepoxide Calcium Salt |
| Catalogue No. | VL10014 |
| CAS No. | N/A |
| Molecular Formula | C33H34FN2O7 |
| Molecular Weight | 589.63 |
| Status | In-stock |
| IUPAC Name | 7-[N-Phenyl-2-[4-(4-fluorophenyl]-6-methylethyl]-3,7-dioxa-5-azatricyclo [4.1.0.02,4]-4-[{phenylamin |
| Appearance | White powder |
| Description | Atorvastatin Diepoxide Calcium Salt (CAS No:N/A) or 7-[N-Phenyl-2-[4-(4-fluorophenyl]-6-methylethyl]-3,7-dioxa-5-azatricyclo [4.1.0.02,4]-4-[{phenylamino}carboxamiide]-(3R,5R)-3,5-dihydroxyheptanoic Acid Calcium Salt. it is rapidly absorbed after oral administration with a peak plasma concentration at 1 to 2 hours and bioavailability is low at 14% due to extensive first-pass metabolism. It helps to prevent cholesterol from building up in your arteries. |
| References | McIver, Lindsey A., and Momin S. Siddique. “Atorvastatin.” Nih.gov, StatPearls Publishing, 5 Jan. 2019, www.ncbi.nlm.nih.gov/books/NBK430779/ |
